QT Imaging (NASDAQ:QTI) Releases Earnings Results, Misses Estimates By $0.11 EPS

Posted by on May 13th, 2026

QT Imaging (NASDAQ:QTI – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.11), Zacks reports.

Here are the key takeaways from QT Imaging’s conference call:

  • QT Imaging said Q1 2026 revenue rose 133% year over year to $6.5 million, driven by shipment of 13 Breast Acoustic CT systems versus 6 in the prior-year quarter.
  • The company highlighted several recent milestones, including FDA 510(k) clearance for an enhancement to improve posterior breast tissue visualization and AMA approval of a new Category 3 CPT code effective January 1, 2027, which it sees as supportive of adoption and future reimbursement.
  • QT Imaging also expanded its international footprint with regulatory classification and clearance in the UAE for both its scanner and QTI SaaS Cloud platform, while management said Saudi approval is still pending and expected soon.
  • Gross margin for the quarter was 41%, down from 65% a year earlier, as operating expenses increased to $5.0 million and cash and equivalents ended the quarter at $7.0 million.
  • Management affirmed full-year 2026 revenue guidance of about $39 million and pointed to contracted scanner orders from distributors, plus early monetization of cloud-based services, as key drivers. The company also extended its senior secured term loan maturity to March 31, 2029, giving it more financial flexibility.

QT Imaging Trading Down 16.7%

NASDAQ:QTI traded down $1.27 during midday trading on Wednesday, reaching $6.32. 238,264 shares of the stock traded hands, compared to its average volume of 39,400. The company has a fifty day moving average of $6.59 and a 200 day moving average of $6.14. QT Imaging has a 12 month low of $0.65 and a 12 month high of $8.50. The company has a debt-to-equity ratio of 0.71, a quick ratio of 2.17 and a current ratio of 2.81. The stock has a market capitalization of $76.09 million, a P/E ratio of -2.89 and a beta of 0.01.

Analysts Set New Price Targets

QTI has been the topic of a number of research analyst reports. Zacks Research raised shares of QT Imaging from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. Lake Street Capital assumed coverage on shares of QT Imaging in a report on Friday, January 30th. They set a “buy” rating for the company. Finally, Weiss Ratings assumed coverage on QT Imaging in a research note on Thursday, January 29th. They issued a “sell (e+)” rating on the stock. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, QT Imaging presently has a consensus rating of “Hold”.

Get Our Latest Stock Analysis on QTI

About QT Imaging

(Get Free Report)

QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.

QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.

Further Reading

Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.